why choose us

First received: November 9, 2022

Clinical Trial: The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19

Study Status: Completed

Recruit Status: Completed

Condition: SARS-CoV-2 Infection

Study Type: Interventional


Official Title: The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19

Brief Summary: The Lateral Flow Antigen Validity and Applicability (LAVA) 2 study aims to determine the validity of lateral flow antigen devices (LFDs) used to perform point of care testing for COVID-19, compared to the current gold standard test of RTPCR in children. In a pilot study we have shown that the anterior nose swabs used to perform a LFD test are associated with significantly lower pain scores than the nose and throat swabs used to perform RT-PCR tests and that the results are available significantly more quickly.…

Read more